Impact of placental abruption on long-term cardiovascular health
Cardiovascular Health After Placental Abruption (CHAP)
This study is looking at how having placental abruption, where the placenta separates too early from the uterus, might affect the heart health of both mothers and their children in the long run, and it's for women who have experienced this condition during pregnancy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10677792 on NIH RePORTER |
What this research studies
This research investigates how placental abruption, a condition where the placenta separates prematurely from the uterus, affects the long-term cardiovascular health of women and their children. The study will analyze rates of cardiovascular and cerebrovascular issues in these individuals, focusing on different severities of abruption and its occurrence in multiple pregnancies. By examining various factors such as preterm delivery and birth weight, the research aims to understand the underlying mechanisms linking placental abruption to future health complications. Participants may contribute to a better understanding of how this obstetric complication can influence long-term health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have experienced placental abruption during pregnancy and are 21 years or older.
Not a fit: Patients who have not experienced placental abruption or are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and preventive strategies for cardiovascular health in women who have experienced placental abruption.
How similar studies have performed: Previous research has shown that complications during pregnancy can have lasting effects on maternal and child health, suggesting that this study's approach is grounded in established findings.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Ananth, Cande V. — Rutgers Biomedical and Health Sciences
- Study coordinator: Ananth, Cande V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.